Cargando…
Emx2 is a dose-dependent negative regulator of Sox2 telencephalic enhancers
The transcription factor Sox2 is essential for neural stem cells (NSC) maintenance in the hippocampus and in vitro. The transcription factor Emx2 is also critical for hippocampal development and NSC self-renewal. Searching for ‘modifier’ genes affecting the Sox2 deficiency phenotype in mouse, we obs...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413107/ https://www.ncbi.nlm.nih.gov/pubmed/22495934 http://dx.doi.org/10.1093/nar/gks295 |
_version_ | 1782240026315194368 |
---|---|
author | Mariani, J. Favaro, R. Lancini, C. Vaccari, G. Ferri, A. L. Bertolini, J. Tonoli, D. Latorre, E. Caccia, R. Ronchi, A. Ottolenghi, S. Miyagi, S. Okuda, A. Zappavigna, V. Nicolis, S. K. |
author_facet | Mariani, J. Favaro, R. Lancini, C. Vaccari, G. Ferri, A. L. Bertolini, J. Tonoli, D. Latorre, E. Caccia, R. Ronchi, A. Ottolenghi, S. Miyagi, S. Okuda, A. Zappavigna, V. Nicolis, S. K. |
author_sort | Mariani, J. |
collection | PubMed |
description | The transcription factor Sox2 is essential for neural stem cells (NSC) maintenance in the hippocampus and in vitro. The transcription factor Emx2 is also critical for hippocampal development and NSC self-renewal. Searching for ‘modifier’ genes affecting the Sox2 deficiency phenotype in mouse, we observed that loss of one Emx2 allele substantially increased the telencephalic β-geo (LacZ) expression of a transgene driven by the 5′ or 3′ Sox2 enhancer. Reciprocally, Emx2 overexpression in NSC cultures inhibited the activity of the same transgene. In vivo, loss of one Emx2 allele increased Sox2 levels in the medial telencephalic wall, including the hippocampal primordium. In hypomorphic Sox2 mutants, retaining a single ‘weak’ Sox2 allele, Emx2 deficiency substantially rescued hippocampal radial glia stem cells and neurogenesis, indicating that Emx2 functionally interacts with Sox2 at the stem cell level. Electrophoresis mobility shift assays and transfection indicated that Emx2 represses the activities of both Sox2 enhancers. Emx2 bound to overlapping Emx2/POU-binding sites, preventing binding of the POU transcriptional activator Brn2. Additionally, Emx2 directly interacted with Brn2 without binding to DNA. These data imply that Emx2 may perform part of its functions by negatively modulating Sox2 in specific brain areas, thus controlling important aspects of NSC function in development. |
format | Online Article Text |
id | pubmed-3413107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-34131072012-08-07 Emx2 is a dose-dependent negative regulator of Sox2 telencephalic enhancers Mariani, J. Favaro, R. Lancini, C. Vaccari, G. Ferri, A. L. Bertolini, J. Tonoli, D. Latorre, E. Caccia, R. Ronchi, A. Ottolenghi, S. Miyagi, S. Okuda, A. Zappavigna, V. Nicolis, S. K. Nucleic Acids Res Gene Regulation, Chromatin and Epigenetics The transcription factor Sox2 is essential for neural stem cells (NSC) maintenance in the hippocampus and in vitro. The transcription factor Emx2 is also critical for hippocampal development and NSC self-renewal. Searching for ‘modifier’ genes affecting the Sox2 deficiency phenotype in mouse, we observed that loss of one Emx2 allele substantially increased the telencephalic β-geo (LacZ) expression of a transgene driven by the 5′ or 3′ Sox2 enhancer. Reciprocally, Emx2 overexpression in NSC cultures inhibited the activity of the same transgene. In vivo, loss of one Emx2 allele increased Sox2 levels in the medial telencephalic wall, including the hippocampal primordium. In hypomorphic Sox2 mutants, retaining a single ‘weak’ Sox2 allele, Emx2 deficiency substantially rescued hippocampal radial glia stem cells and neurogenesis, indicating that Emx2 functionally interacts with Sox2 at the stem cell level. Electrophoresis mobility shift assays and transfection indicated that Emx2 represses the activities of both Sox2 enhancers. Emx2 bound to overlapping Emx2/POU-binding sites, preventing binding of the POU transcriptional activator Brn2. Additionally, Emx2 directly interacted with Brn2 without binding to DNA. These data imply that Emx2 may perform part of its functions by negatively modulating Sox2 in specific brain areas, thus controlling important aspects of NSC function in development. Oxford University Press 2012-08 2012-04-10 /pmc/articles/PMC3413107/ /pubmed/22495934 http://dx.doi.org/10.1093/nar/gks295 Text en © The Author(s) 2012. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Gene Regulation, Chromatin and Epigenetics Mariani, J. Favaro, R. Lancini, C. Vaccari, G. Ferri, A. L. Bertolini, J. Tonoli, D. Latorre, E. Caccia, R. Ronchi, A. Ottolenghi, S. Miyagi, S. Okuda, A. Zappavigna, V. Nicolis, S. K. Emx2 is a dose-dependent negative regulator of Sox2 telencephalic enhancers |
title | Emx2 is a dose-dependent negative regulator of Sox2 telencephalic enhancers |
title_full | Emx2 is a dose-dependent negative regulator of Sox2 telencephalic enhancers |
title_fullStr | Emx2 is a dose-dependent negative regulator of Sox2 telencephalic enhancers |
title_full_unstemmed | Emx2 is a dose-dependent negative regulator of Sox2 telencephalic enhancers |
title_short | Emx2 is a dose-dependent negative regulator of Sox2 telencephalic enhancers |
title_sort | emx2 is a dose-dependent negative regulator of sox2 telencephalic enhancers |
topic | Gene Regulation, Chromatin and Epigenetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413107/ https://www.ncbi.nlm.nih.gov/pubmed/22495934 http://dx.doi.org/10.1093/nar/gks295 |
work_keys_str_mv | AT marianij emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT favaror emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT lancinic emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT vaccarig emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT ferrial emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT bertolinij emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT tonolid emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT latorree emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT cacciar emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT ronchia emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT ottolenghis emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT miyagis emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT okudaa emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT zappavignav emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers AT nicolissk emx2isadosedependentnegativeregulatorofsox2telencephalicenhancers |